Monday, November 14, 2016

BRIEF-Abbvie's Humira (adalimumab) receives CHMP positive opinion to treat adolescents with Hidradenitis Suppurativa

* Abbvie's Humira receives CHMP positive opinion to treat

adolescents with Hidradenitis Suppurativa, a chronic

inflammatory skin disease

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)